Lilly extends assistance plan for Medicare-eligible
Patients eligible for but not yet enrolled in Medicare Part D cancontinue to receive medications through Eli Lilly's LillyAnswerspatient assistance program through the end of the year. To continueto receive the drugs, patients must have been enrolled inLillyAnswers as of last December.
Lilly extends assistance plan for Medicare-eligible
Patients eligible for but not yet enrolled in Medicare Part D can continue to receive medications through Eli Lilly's LillyAnswers patient assistance program through the end of the year. To continue to receive the drugs, patients must have been enrolled in LillyAnswers as of last December. Lilly has asked the Inspector General for a legal opinion on its proposal to extend assistance beyond the end of the year to Medicare patients taking Forteo (teriparatide [rDNA origin] injection) or Zyprexa (olanzapine).
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
